These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 8535218)
1. Regression of experimental human leukemias and solid tumors induced by Epstein-Barr virus-immortalized B cells. Angiolillo AL; Sgadari C; Sheikh N; Reaman GH; Tosato G Leuk Lymphoma; 1995 Oct; 19(3-4):267-76. PubMed ID: 8535218 [TBL] [Abstract][Full Text] [Related]
2. Regression of experimental Burkitt's lymphoma induced by Epstein-Barr virus-immortalized human B cells. Tosato G; Sgadari C; Taga K; Jones KD; Pike SE; Rosenberg A; Sechler JM; Magrath IT; Love LA; Bhatia K Blood; 1994 Feb; 83(3):776-84. PubMed ID: 8298139 [TBL] [Abstract][Full Text] [Related]
3. Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells. Wolf J; Draube A; Bohlen H; Jox A; Mücke S; Pawlita M; Möller P; Diehl V Int J Cancer; 1995 Feb; 60(4):527-33. PubMed ID: 7829268 [TBL] [Abstract][Full Text] [Related]
4. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice. Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726 [TBL] [Abstract][Full Text] [Related]
5. Biology and virology of the human malignant lymphomas: 1st Milford D. Schulz Lecture. Kaplan HS; Goodenow RS; Gartner S; Bieber MM Cancer; 1979 Jan; 43(1):1-24. PubMed ID: 83902 [TBL] [Abstract][Full Text] [Related]
6. A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12. Angiolillo AL; Sgadari C; Tosato G Ann N Y Acad Sci; 1996 Oct; 795():158-67. PubMed ID: 8958926 [TBL] [Abstract][Full Text] [Related]
7. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient. Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990 [TBL] [Abstract][Full Text] [Related]
8. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Wolf J; Pawlita M; Bullerdiek J; zur Hausen H Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373 [TBL] [Abstract][Full Text] [Related]
9. Human B-lymphoid cell lines. Nilsson K Hum Cell; 1992 Mar; 5(1):25-41. PubMed ID: 1329931 [TBL] [Abstract][Full Text] [Related]
10. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines. Perez-Chacon G; de Los Rios C; Zapata JM Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456 [TBL] [Abstract][Full Text] [Related]
11. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA). Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866 [TBL] [Abstract][Full Text] [Related]
12. Establishment of an Epstein-Barr virus-negative B-cell lymphoma line from a Japanese Burkitt's lymphoma and its serial passage in hamsters. Miyoshi I; Hiraki S; Kubonishi I; Matsuda Y; Kishimoto H; Nakayama T; Tanaka T; Masuji H; Kimura I Cancer; 1977 Dec; 40(6):2999-3003. PubMed ID: 201360 [TBL] [Abstract][Full Text] [Related]
13. In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes. Daibata M; Taguchi T; Nemoto Y; Iwasaki S; Ohtsuki Y; Taguchi H Int J Cancer; 2006 Jan; 118(2):513-7. PubMed ID: 16049984 [TBL] [Abstract][Full Text] [Related]
14. Athymic nude mice: induction of tumors containing Epstein-Barr virus using Burkitt's-related cell lines. Ablashi DV; Glaser R; Easton JM; Nonoyama M; Armstrong GR Exp Hematol; 1978 Apr; 6(4):365-74. PubMed ID: 206453 [TBL] [Abstract][Full Text] [Related]
15. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss. Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002 [TBL] [Abstract][Full Text] [Related]
16. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas. Yokochi T; Holly RD; Clark EA J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961 [TBL] [Abstract][Full Text] [Related]
17. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies. Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774 [TBL] [Abstract][Full Text] [Related]
19. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis. Guedez L; McMarlin AJ; Kingma DW; Bennett TA; Stetler-Stevenson M; Stetler-Stevenson WG Am J Pathol; 2001 Apr; 158(4):1207-15. PubMed ID: 11290537 [TBL] [Abstract][Full Text] [Related]